Rationale & objective:The identification of pathogenic variants in genes associated with chronic kidney disease can provide patients and nephrologists with actionable information to guide diagnoses and therapeutic plans. However, many nephrologists do not use genetic testing despite costs decreasing over time...
According to WHO, chronic kidney diseases affect more than 10% of the general population worldwide, amounting to more than 800 million individuals.[3] Even though chronic kidney disease is one of the top ten leading causes of death, in low- and middle-income countries/regions, its awareness ...
Guideline-based testing for chronic kidney disease Assess kidney function and damage with help from guideline-based testing, for a more complete picture of your patient’s kidney health Chronic kidney disease (CKD) affects 37 million people in the US, but the vast majority don’t know they ha...
Chronic kidney disease (CKD) is common in the United States. The estimated prevalence of CKD in US adults was 11.7% ± 0.8% in 2000, based on the National Health and Nutrition Examination Survey (NHANES). Global estimates for CKD prevalence are less certain, but recent studies in Europe, ...
Results from the EMPA-REG OUTCOME trial suggests empagliflozin (Jardiance) has potential in the treatment of chronic kidney disease.
Bhalla A, Raible D, Balaraman V, Talwar M. Broad Panel Genetic Testing for Chronic Kidney Disease in the Transplant Center [abstract].Am J Transplant.2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/broad-panel-genetic-testing-for-chronic-kidney-disease-in-the-t...
1 For a summary for recommended monitoring frequencies, please refer to Laboratory Testing for Chronic Kidney Disease Diagnosis and Management. In addition, the Kidney Failure Risk equation (KidneyFailureRisk.com) uses ACR and eGFR to estimate the risk of persons developing CK...
(3)Harvard Radiation Oncology Program, Boston, Massachusetts.doi:10.1001/jamainternmed.2015.17Mallika L. MenduAndrew LundquistAyal A. AizerDavid E. LeafEmily RobinsonDavid J. R. SteeleSushrut S. WaikarJama ...
Chronic Kidney Disease: FSGS, Genetic Testing, and APOL1 Matthew A. Sparks, MD; Kirk Campbell, MD Disclosures September 26, 2023 1This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your ...
The updated guideline includes consensus statements supporting the use of genetic testing to establish the cause of chronic kidney disease (CKD) for a majority of patients with this condition. The KDIGO guideline, specifically in Practice Points 1.1.4.1 and 1.1.4....